Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa

Clinical trial NCT01263379 · COMPLETED

Trial details

NCT number: NCT01263379
Sponsor: Abeona Therapeutics, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Dystrophica Epidermolysis Bullosa

Start date: 2010-10-05
Primary completion: 2022-03-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.